, 5 FcgRIIb is the sole inhibitory FcR for IgG in humans and mice, where it is involved in the negative regulation of Ab production and cellular activation. FcgRIIb-deficient mice show exacerbated disease following the induction of nephrotoxic nephritis (NTN). In this study, we determined the cellular origin of the FcgRIIb-knockout phenotype by inducing NTN in mice with a deficiency of F cgRIIb is a low-affinity FcR for the constant part of IgG and the sole inhibitory FcgR in both humans and mice. It is the most broadly expressed, being found on most cells of myeloid lineage, and it is the only FcgR found on B cells. On B cells, cross-linking of FcgRIIb and the BCR activates a distinct pathway that inhibits cell proliferation, maturation, and the production of cytokines (1); however, cross-linking of FcgRIIb in the absence of the BCR initiates a bim-dependent apoptosis pathway (2) . Reduced expression of FcgRIIb is associated with enhanced activation and proliferation of B cells and plasma cells (3) , as well as increased Ab production to T-dependent Ags (3, 4) and increased macrophage activation by immune complexes (4) (5) (6) .
Reduced functionality of FcgRIIb has been associated with systemic lupus erythematosus in humans (7) , and several autoimmune strains of mice have a polymorphism in the promoter region of the FcgRIIb gene that is associated with reduced cellsurface expression on macrophages and activated B cells (5) . When combined with other autoimmune susceptibility genes, mice deficient in FcgRIIb develop systemic lupus erythematosus, whereas on a pure C57BL/6 background, they do not develop severe autoimmunity, indicating that FcgRIIb is a modifier of autoimmune susceptibility determined by other genetic loci. However, C57BL/6 FcgRIIb 2/2 mice do show enhanced Ab responses and are highly susceptible to anti-glomerular basement membrane Ab disease and nephrotoxic nephritis (NTN) (8) (9) (10) . This could be due to increased Ab production by FcgRIIb-deficient B cell lineages or, alternatively, due to increased myeloid cell activation. Mesangial cells have also been shown to express FcgRIIb (11, 12) , adding another possible checkpoint in the prevention of severe Abmediated glomerulonephritis. The model of NTN (accelerated NTN) used in this study is a well-characterized disease model that closely resembles human Ab-mediated glomerulonephritis. The animals are preimmunized against sheep IgG. Five days later, the mice are injected i.v. with polyclonal sheep anti-mouse glomerular basement membrane Ab, which is then planted on the mouse glomerular basement membrane. As the mice are presensitized to sheep IgG, this results in immediate generation and deposition of mouse anti-sheep Ig in the glomerulus, which progresses over several days and leads to cellular infiltration of neutrophils, followed by macrophages, proteinuria, glomerular injury, glomerular crescents, and, in severe cases, progressive uremia. Previous studies of murine NTN have highlighted roles for the involvement of many immune effectors in glomerulonephritis, including macrophages, FcgR, Th1 and Th17 cells, complement, and intrinsic renal cells.
In order to determine the role of FcgRIIb on specific cell types in NTN, we have crossed floxed FcgRIIb mice on a C57BL/6 background with mice expressing Cre recombinase either under control of the human CD19 promoter to delete FcgRIIb in only B cell lineages or under control of the CEBPa promoter to delete FcgRIIb in myeloid lineages. The cell-type-specific FcgRIIbknockout offspring have been compared with littermate controls. Because a Cre-transgenic strain that expresses Cre under control of a mesangial cell-specific promoter was not available, we have created bone marrow chimeras to determine the role of FcgRIIb on radioresistant cells in the kidney.
Materials and Methods

Mice
The FcgRIIb 2/2 (C57BL/6) mice were generated in Leiden University Medical Center as previously described (4). CD19Cre mice were kindly provided by Ari Waisman (Cologne, Germany) (13) . CEBPaCre mice were kindly provided by Dr. Ivo Touw (Rotterdam, The Netherlands) (14) . All mice were on a C57BL/6 background. Littermate wild-type (WT) controls were used. Mice were bred and housed in the animal facility at Leiden University Medical Centre (Leiden, The Netherlands). Experiments were performed in accordance with the regulations of the ethics committee at Leiden University Medical Center. Analysis of serology and histology was performed at Imperial College London. For experiments involving bone marrow-transplanted mice, FcgRIIb 2/2 (C57BL/6) mice were bred at the Biological Services Unit, Hammersmith Hospital (London, U.K.). Control age-and sex-matched C57BL/6 WT mice were purchased from Charles River Laboratories. All mice were housed with free access to food and water and kept in a specific pathogen-free environment, according to institutional guidelines. Experiments were performed under the terms of a license issued by the UK Home Office. All mice used in this study were between 6 and 15 wk of age.
Phenotyping expression of FcgRIIb by flow cytometry
Heparinized whole blood was obtained and stained for CD11b, CD19, Gr-1 (BD Pharmingen), and FcgRIIb (clone Ly17.2). Spleen was digested with liberase TL to release resident macrophages from connective tissue. Single-cell suspensions were prepared, and cells were stained for CD11b, F4/80, CD11c, CD19, and FcgRIIb. Blood and spleen were obtained from 
Induction of accelerated nephrotoxic nephritis
Sheep anti-mouse nephrotoxic globulin was prepared as described previously (15) . Mice were preimmunized i.p. with 0.2 mg sheep IgG in a 50:50 mix of saline and CFA (Sigma-Aldrich, Dorset, U.K.). Five days later, mice were injected i.v. with 0.2 ml nephrotoxic globulin via the tail vein. Mice were monitored clinically by using dipstick for detection of proteinuria and hematuria, and the experiments were terminated if the mice showed signs of ill health.
Histology and immunohistochemistry
Glomerular crescents and thrombosis were scored on samples fixed in Bouin's solution and stained with periodic acid-Schiff (PAS) reagent. Histological samples were assessed by an observer blinded to the experimental group. Crescents were defined as two or more layers of cells in the Bowman's space. Glomerular thrombosis was assessed by scoring individual glomeruli for PAS-positive material: grade 0, no PAS-positive material; grade 1, 0-25% of the glomerular section PAS positive; grade 2, 25-50%; grade 3, 50-75%; and grade 4, 75-100%. Fifty glomeruli were scored for crescents and thrombosis for each kidney, and a mean was calculated.
Glomerular mouse and sheep IgG were visualized by direct immunofluorescence staining on 5-mm frozen kidney sections fixed in acetone for 10 min using FITC-conjugated goat anti-mouse IgG (Fc-specific) (Sigma-Aldrich) and FITC-conjugated monoclonal mouse anti-sheep IgG clone GT34 (Sigma-Aldrich). To quantitate immunofluorescence, sections were examined at 340 original magnification using an Olympus BX4 fluorescence microscope (Olympus Optical, London, U.K.) and a Photonic Science Color Coolview camera (Photonic Science, Robertsbridge, U.K.). Samples from each experiment were stained on the same occasion and measured together. Images of the sections were captured using Image Pro (MediaCybernetics, Bethesda, MD), and the total pixel intensity for each glomerulus was measured and averaged for 20 glomeruli per section.
For cell markers, kidneys were fixed in periodate-lysine-paraformaldehyde. Sections of 5 mm were stained for macrophages with FA11 (monoclonal rat anti-mouse CD68; Serotec, Oxford, U.K.) and neutrophils with Gr-1 (monoclonal rat anti-mouse; Serotec) and developed using the Polink-2 plus HRP rat detection kit (Newmarket Scientific, Newmarket, U.K.). Macrophages and neutrophils in 50 glomeruli/sample were counted and averaged to obtain cells/glomerular cross-section (gcs).
Renal function and proteinuria
Urinary creatinine was measured in the Department of Clinical Chemistry, Imperial College Healthcare NHS Trust. Serum albumin was measured using the AssayMax mouse albumin ELISA kit (AssayPro, St. Charles, MO). Serum urea was measured using the Urea/Ammonia ultraviolet-method kit (R-Biopharm, Darmstadt, Germany). Albuminuria was assessed by radial immunodiffusion against a rabbit anti-mouse albumin (Biogenesis, Poole, U.K.), as previously described (15) .
Bone marrow chimeras
Chimeric mice were made by irradiation with a dose of 8 Gy and reconstituted with 10 3 10 6 donor bone marrow cells. Nephritis experiments were conducted at 10 wk posttransplant. Confirmation of chimerism was obtained using PCR on DNA extracted from 0.1 ml blood obtained at the terminal bleed, as previously described (4) .
Mesangial cell cultures
Kidneys from WT and FcgRIIb 2/2 mice were homogenized with a syringe plunger and forced through a series of sterile sieves with successively smaller pore sizes of 150, 106, and 45 mm. Glomeruli retained on the 45-mm sieve were retrieved, washed in ice-cold PBS, and spun down at 1000 rpm for 5 min. Glomeruli were digested with 380 U/ml collagenase (Sigma-Aldrich) for 30 min at 37˚C, spun down 1200 rpm for 5 min, and resuspended in RPMI 1640 (Invitrogen) supplemented with 20% FCS (Biosera), 100 U/ml penicillin, 100 g/ml streptomycin (Invitrogen), and 1% insulin/selenium/transferrin growth supplement (Sigma-Aldrich). Mesangial cells were characterized as anti-myosin positive and pancytokeratin negative, with characteristic stellate morphology.
Mesangial cell FcgRIIb expression
Expression of FcgRIIb on mesangial cells was confirmed by direct immunofluorescence on cytospin preparations. Briefly, cytospin slides were prepared, air-dried, and cells fixed in acetone for 10 min and stained with FITC-conjugated anti-FcgRIIb Ab (clone Ly17.2). Immunofluorescence was visualized at 340 original magnification using an Olympus BX4 fluorescence microscope (Olympus Optical) and a Photonic Science Color Coolview camera (Photonic Science, Robertsbridge, U.K.). Images of the sections were captured using Image Pro (MediaCybernetics, Bethesda, MD).
Quantitative real-time PCR was performed as previously described (16) using FcgRIIb-specific primers (12) and normalizing to GAPDH.
Statistics
Results are quoted as median (interquartile range), unless otherwise stated. Lines on graphs represent median values. For comparing two groups, the Mann-Whitney U test was used, and for three or more groups, the KruskalWallis test was used, with Dunn's multiple comparisons test (p values given are from Dunn's test). GraphPad Prism (GraphPad Software, San Diego, CA) was used to analyze the data. Differences were considered significant when p , 0.05. (Fig. 1A) . In FcgRIIb fl/fl /CEBPaCre + mice, there was excellent deletion from circulating monocytes and granulocytes and partial deletion from splenic macrophages and dendritic cells, with no effect on B cell expression of FcgRIIb (Fig. 1B) Fig. 2A-D) .
Results
Phenotype of FcgRIIb conditional knockouts
These results demonstrate that lack of FcgRIIb on B cells alone was not sufficient to worsen NTN compared with WT mice, whereas mice with the full deletion of FcgRIIb under the same conditions (5 d after the induction of NTN) had markedly increased disease. This suggests the involvement of FcgRIIb on cell types other than B cells in the protection from NTN.
Mice lacking FcgRIIb on myeloid cells were more susceptible to NTN than WT (Fig. 3B, 3C) . Surprisingly, there was no significant difference in glomerular macrophage infiltration among WT, FcgRIIb 
Role of FcgRIIb in intrinsic renal cells
Although FcgRIIb fl/fl /CEBPaCre + mice had increased NTN compared with WT mice, their disease susceptibility was not as marked as mice with a full deletion of FcgRIIb, as they were able to tolerate a higher dose of NTS and be maintained longer than mice with the full deletion of FcgRIIb. In addition, it was possible to titrate the dose of NTS down such that FcgRIIb fl/fl /CEBPaCre + mice developed little disease, whereas mice with a full deletion of FcgRIIb continued to have increased susceptibility to disease compared with WT controls (data not shown). This may be due to the fact that the deletion of FcgRIIb from myeloid cells in the conditional knockout was not absolutely complete (Fig. 1B) . However, expression of FcgRIIb on intrinsic renal cells has previously been reported (11) , and an FcgRIIb on intrinsic renal cells was suggested by experiments in which a blocking anti-FcgRIIb Ab was injected under the kidney capsule (17) . We therefore sought to determine whether there was a contribution of disease susceptibility from intrinsic renal cells to explain the slightly increased susceptibility to disease in the full FcgRIIb 2/2 mice compared with FcgRIIb fl/fl /CEBPaCre + mice.
Expression of FcgRIIb by mesangial cells
Expression of FcgRIIb by cultured mesangial cells was assessed by real-time quantitative PCR. Transcripts were detected in WT mesangial cells, and stimulation with LPS increased the expression, although not significantly. No transcripts were detected in FcgRIIbdeficient mesangial cells (data not shown). We also assessed 
Expression of FcgRIIb on radioresistant cells in the kidney induced relative protection from NTN compared with mice with a full deletion of FcgRIIb
Unfortunately, a mouse with mesangial cell-specific Cre-recombinase expression is not available. We therefore used bone marrow chimeric mice to investigate the role of FcgRIIb on radioresistant intrinsic renal cells. By transplanting CD45.1 allogeneic bone marrow into CD45.2 mice and using flow cytometry of blood and dissociated kidney cells, our previous studies have shown that our method of bone marrow transplantation results in 95% replacement of resident renal CD68-positive macrophages and CD11c-positive dendritic cells, as well as excellent chimerism of circulating neutrophils, monocytes, and B cells (16 (Fig. 6E, 6F ). These results suggest that, in addition to the role of myeloid FcgRIIb in protection from immune complex glomerulonephritis, FcgRIIb on intrinsic renal cells may also play a role in protection from disease. Subsequently, the reciprocal experiment was performed to determine whether the lack of FcgRIIb on intrinsic renal cells alone was sufficient to increase susceptibility to NTN. Mild disease was again induced with a low dose of NTS, and the mice were maintained to day 14 after injection of NTS. The disease induced in both groups was mild, and there was no overall difference in glomerular crescents and thrombosis. The degree of albuminuria in both groups was minimal in most animals, but there was a statistically significant increase in the FcgRIIb 2/2 mice transplanted with WT bone marrow compared with WT mice transplanted with WT bone marrow (p , 0.01) (Fig 7C) . There were also more glomerular infiltrating macrophages in the FcgRIIb 2/2 mice transplanted with WT bone marrow than the WT mice transplanted with WT bone marrow (Fig. 7D , p , The Journal of Immunology0.01). There was no significant difference in deposited glomerular mouse IgG or circulating anti-sheep IgG between the two groups (Fig. 7E, 7F ).
Discussion
Despite a good deletion of FcgRIIb from B cells, the FcgRIIb fl/fl / CD19Cre + mice did not show increased susceptibility to NTN compared with WT mice. However, mice with FcgRIIb deleted from their myeloid cells had increased susceptibility to NTN compared with WT littermate controls. This is important direct evidence of a role of myeloid rather than B cell FcgRIIb in protection from glomerulonephritis. Additionally, we have confirmed expression of FcgRIIb on cultured mesangial cells, and our results would suggest that in addition to myeloid cell expression, local expression of FcgRIIb on intrinsic renal cells contributes to protection from injury in NTN.
These results support our previous work looking at a model of experimental autoimmune glomerulonephritis in FcgRIIb-deficient mice on a pure C57BL/6 background, where we also found that loss of FcgRIIb on B cells alone was not sufficient to exacerbate experimental autoimmune glomerulonephritis (10) . In contrast, transgenic overexpression of FcgRIIb on B cells was found to reduce the severity of collagen-induced arthritis in mice as well as lower the level of anti-collagen Abs (18) . Our results suggest that in glomerulonephritis, B cell expression of FcgRIIb is not the sole determinant of protection from injury.
Deletion of FcgRIIb on B cells results in hyperreactive B cells that produce increased Ab titers in response to both thymusdependent and -independent Ags (3). We did see a wide range of anti-sheep Ab titers in our experiments, and the results were also complicated by the presence of renal disease and proteinuria. Nevertheless, we did see increased levels of deposited murine IgG in mice lacking FcgRIIb on B cells, supporting the presence of increased levels of Ab throughout the disease course. Full FcgRIIb 2/2 mice had slightly lower levels of circulating antisheep total IgG than WT mice, for unknown reasons, possibly due to heavy proteinuria (Fig. 2E) . (17), suggesting FcgRIIb may play a role in the negative regulation of neutrophil recruitment. Surprisingly, there was no significant difference in glomerular macrophage infiltration between the WT mice and myeloid cell knockouts. FcgRIIb clearly plays a role in the recruitment of macrophages to the glomerulus, as the FcgRIIb-deficient mice had significantly greater macrophage infiltration than WT mice. This suggests that expression of FcgRIIb on macrophages is not critical for their recruitment. This is supported by previous work looking at the role of activating FcgR in NTN. There was no significant difference in glomerular macrophage infiltration among WT mice, WT mice transplanted with FcRg 2/2 bone marrow, and FcRg 2/2 mice transplanted with FcRg 2/2 bone marrow (15) . Despite similar numbers of infiltrating macrophages among the three groups of mice, FcgRIIb fl/fl /CEBPaCre + mice had increased disease. This could be explained by the fact that the macrophages are likely to show enhanced activation. Reduced surface expression of FcgRIIb on macrophages was associated with heightened responses following activatory FcgR cross-linking, including increased intracellular calcium flux, superoxide production, and proinflammatory cytokine release (5, 6, 19) . On the contrary, administration of i.v. Ig (IVIG) in accelerated NTN was found to upregulate FcgRIIb on effector macrophages in the kidney and protected mice from fatal disease (20) . Indeed, IVIG was not effective in protecting FcgRIIb 2/2 mice from NTN, indicating that this is an important mechanism of action for IVIG (20) . Th2 cytokines, such as IL-4, are known to increase myeloid expression of FcgRIIb (21) . Recently, it has been determined that the sialylated IgG component of human IVIG binds to a lectin receptor dendritic cell-specific intracellular adhesion molecule 3-grabbing nonintegrin on dendritic cells, leading to the secretion of IL-33, which upregulates IL-4 secretion by basophils and leads to the increased expression of FcgRIIb on myeloid cells (22) . Taken together with our results, these findings offer insights into the mechanism of action of IVIG for the treatment of human autoimmune disease, specifically the critical importance of FcgRIIb expression on myeloid cells in the protection from Ab-mediated injury (23) .
We have confirmed expression of FcgRIIb on mesangial cells in culture. However, due to the absence of a mesangial cellspecific Cre, bone marrow chimeras were used to investigate the role of FcgRIIb on radioresistant cells, and therefore, we are not able categorically to determine the radioresistant cell type involved. WT mice transplanted with FcgRIIb 2/2 bone marrow were not as susceptible to NTN as FcgRIIb 2/2 mice transplanted with FcgRIIb 2/2 bone marrow. PCR of blood-derived DNA demonstrated that at least 95% of circulating DNA was of donor origin, in addition to our previous work showing that there is a similar high degree of chimerism of resident macrophages and dendritic cells in the kidney (16) . Bone marrow-derived cells of recipient origin are therefore unlikely to explain the significant differences mice. 2/2 transplanted into 2/2 (n = 10), 2/2 transplanted between these two groups, and it is likely that FcgRIIb on radioresistant intrinsic renal cells plays a part in protecting from immune complex glomerulonephritis. In the converse experiment, in which WT bone marrow was transplanted to FcgRIIb mice and compared with WT mice transplanted with WT marrow, the evidence for lack of FcgRIIb on intrinsic renal cells alone to exacerbate NTN significantly was weaker. We did see an increase in the glomerular macrophage infiltration in the FcgRIIb 2/2 mice transplanted with WT bone marrow compared with WT controls, but other renal parameters were not significantly different. Therefore, the presence of FcgRIIb on intrinsic renal cells was sufficient to afford some protection from NTN, but the lack of FcgRIIb on radioresistant cells alone was not sufficient to exacerbate disease significantly. Although expression of FcgRIIb on radioresistant cells, possibly mesangial cells, did appear to afford some protection from NTN, we did not see protection from disease in mice lacking activatory FcgR from intrinsic renal cells in our previous work (15) . These data suggest FcgRIIb may be interacting with an alternative receptor on mesangial cells. For instance, a negative regulatory interaction between FcgRIIb and the C5a receptor has been implicated in a recently published study (24) .
Interestingly, in both of the transplant experiments, mice lacking FcgRIIb on their intrinsic renal cells had more glomerular macrophage influx than mice with WT intrinsic renal cells. Taken with the observations that mice completely lacking FcgRIIb also had increased glomerular macrophage infiltration compared with WT mice, but mice with FcgRIIb only deleted from myeloid cells did not, this suggests that FcgRIIb expression by intrinsic renal cells, such as mesangial cells, acts to downregulate recruitment of macrophages to the glomerulus. It also appears that macrophage recruitment can be uncoupled from macrophage activation, as there was only an increase in disease when FcgRIIb was not expressed on the macrophages themselves rather than the intrinsic renal cells.
In summary, deletion of FcgRIIb on B cells alone was not sufficient to exacerbate NTN, indicating that enhanced Ab production does not contribute to disease in this model. However, deletion of FcgRIIb on myeloid cells did increase susceptibility to renal injury in the mice, confirming the important regulatory function of this inhibiting FcgR on myeloid cells in Ab-mediated inflammatory diseases. Therapeutic means to enhance the expression of FcgRIIb on myeloid cells have the potential to be of importance in the treatment of human glomerulonephritis.
